Ex-vivo CD19+ B cells from PBC patients produced increased inflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) compared to CD19+ cells from healthy controls (73). Here, CD19 is linked to primary biliary cholangitis.